Irodalom:
1. Ramakrishnan K, Salinas RC: Peptic ulcer disease. Am Fam Physician 2007; 76: 1005-12
2. Uchio Y, Mori R, Iwasa J, Kakimaru H, Yamamoto S, Yamaguchi H, Miyamoto W: The effect of non-steroidal
anti-inflammatory drugs on upper gastrointestinal disorders in orthopaedic patients. Nippon Rinsho.
2007; 65: 1906-11.
3. Yamagata M, Hiraishi H: Prevalence and incidence of NSAID-induced gastrointestinal ulcers and
bleeding. Nippon Rinsho. 2007; 65: 1749-53.
4. García Rodríguez LA, Barreales Tolosa L: Risk of upper gastrointestinal complications among users of
traditional NSAIDsand COXIBs in the general population. Gastroenterology. 2007; 132: 498-506.
5. Ziegelin M, Hoschtitzky A, Dunning J, Hooper T: Does clopidogrel rather than aspirin plus a protonpump
inhibitor reduce the frequency of gastrointestinal complications after cardiac surgery? Interact
Cardiovasc Thorac Surg. 2007; 6: 534-7.
6. Steen KS, Nurmohamed MT, Visman I, Heierman M, Boers M, Dijkmans BA, Lems WF: Decreasing
incidence of symptomatic gastrointestinal ulcers and ulcer complications in patients with rheumatoid
arthritis. Ann Rheum Dis. 2007. Epub ahead of print.
7. Van Soest EM, Sturkenboom MC, Dieleman JP, Verhamme KM, Siersema PD, Kuipers EJ: Adherence
to gastroprotection and the risk of NSAID-related upper gastrointestinal ulcers and haemorrhage. Aliment
Pharmacol Ther. 2007; 26: 265-75.
8. Kamada T, Kusunoki H, Manabe N, Shiotani A, Hata J, Haruma K: Histamine-2 receptor antagonists.
Nippon Rinsho. 2007; 65: 1835-40.
9. Yamao J, Kikuchi E, Matsumoto M, Nakayama M, Ann T, Kojima H, Mitoro A, Yoshida M, Yoshikawa M,
Yajima H, Miyauchi Y, Ono H, Akiyama K, Sakurai G, Kinoshita Y, Haruma K, Takakura Y, Fukui H:
Assessing the efficacy of famotidine and rebamipide in the treatment of gastric mucosal lesions in
patients receiving long-term NSAID therapy (FORCE–famotidine or rebamipide in comparison by endoscopy).
J Gastroenterol. 2006; 41: 1178-85.
10. Ray WA, Chung CP, Stein CM, Smalley WE, Hall K, Arbogast PG, Griffin MR: Risk of peptic ulcer
hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs. Gastroenterology.
2007; 133: 790-8.
11. Höer A, Gothe H, Schiffhorst G, Sterzel A, Grass U, Hûussler B: Comparison of the effects of diclofenac
or other non-steroidal anti-inflammatory drugs (NSAIDs) and diclofenac or other NSAIDs in combination
with proton pump inhibitors (PPI) on hospitalisation due to peptic ulcer disease. Pharmacoepidemiol
Drug Saf. 2007; 16: 854-8.
12. Yanaka A, Zhang S, Sato D, Tauchi M, Suzuki H, Shibahara T, Matsui H, Nakahara A, Hyodo I:
Geranylgeranylacetone protects the human gastric mucosa from diclofenac-induced injury via induction
of heat shock protein 70. Digestion. 2007; 75: 148-55.
13. Nishio H, Terashima S, Nakashima M, Aihara E, Takeuchi K: Involvement of prostaglandin E receptor
EP3 subtype and prostacyclin IP receptor in decreased acid response in damaged stomach. J Physiol
Pharmacol. 2007; 58: 407-21.
14. Arisawa T, Hirata I: Genetic polymorphism of COX-1 gene and NSAID-induced ulcer. Nippon Rinsho.
2007; 65: 1885-9.
A gyomor 121
15. Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Nakamura M, Yoshioka D,
Arima Y, Okubo M, Hirata I, Nakano H: Association between genetic polymorphisms in the
cyclooxygenase-1 gene promoter and peptic ulcers in Japan. Int J Mol Med. 2007; 20: 373-8.
16. de Leest HT, Steen KS, Lems WF, Bijlsma JW, van de Laar MA, Huisman AM, Vonkeman HE, Houben
HH, Kadir SW, Kostense PJ, van Tulder MW, Kuipers EJ, Boers M, Dijkmans BA: Eradication of
Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID
treatment: double-blind, randomized, placebo-controlled trial. Helicobacter. 2007; 12: 477-85.
17. Pilotto A, Seripa D, Franceschi M, Scarcelli C, Colaizzo D, Grandone E, Niro V, Andriulli A, Leandro G,
Di Mario F, Dallapiccola B: Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastro
duodenal bleeding: role of cytochrome P450 2C9 polymorphisms. Gastroenterology. 2007; 133: 465-71.
18. Jansson EA, Petersson J, Reinders C, Sobko T, Björne H, Phillipson M, Weitzberg E, Holm L, Lundberg JO:
Protection from nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers by dietary nitrate.
Free Radic Biol Med. 2007; 42: 510-8.
19. Murat N, Gidener S, Koyuncuoglu M, Yilmaz O: The effect of nonsteroidal anti-inflammatory drugs on rat
gastric mucosa. The role of endothelin. Saudi Med J. 2007; 28: 612-6.
20. Filaretova L, Podvigina T, Bagaeva T, Bobryshev P, Takeuchi K: Gastroprotective role of glucocorticoid
hormones. J Pharmacol Sci. 2007; 104: 195-201.
21. Walker J, Robinson J, Stewart J, Jacob S: Does enteric-coated aspirin result in a lower incidence of
gastrointestinal complications compared to normal aspirin? Interact Cardiovasc Thorac Surg. 2007; 6: 519-22.
22. Wallace JL: Building a better aspirin: gaseous solutions to a century-old problem. Br J Pharmacol. 2007;
152: 421-8.
23. Goldstein JL, Cryer B, Amer F, Hunt B: Celecoxib plus aspirin versus naproxen and lansoprazole plus
aspirin: a randomized, double-blind, endoscopic trial. Clin Gastroenterol Hepatol. 2007; 5: 1167-74.
24. Laine L, Curtis SP, Cryer B, Kaur A, Cannon CP; MEDAL Steering Committee: Assessment of upper
gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis
in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised
comparison. Lancet. 2007; 369: 465-73.
25. Maiden L, Thjodleifsson B, Seigal A, Bjarnason II, Scott D, Birgisson S, Bjarnason I: Long-term effects
of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a
cross-sectional capsule enteroscopy study. Clin Gastroenterol Hepatol. 2007; 5: 1040-5.
